OverviewChartNewsTraderScreen

UBS Call 78 AZN 21.03.2025/  DE000UM6B2T6  /

EUWAX
1/24/2025  9:07:34 AM Chg.+0.002 Bid10:00:19 PM Ask10:00:19 PM Underlying Strike price Expiration date Option type
0.080EUR +2.56% -
Bid Size: -		 -
Ask Size: -		 AstraZeneca PLC 78.00 - 3/21/2025 Call
TeleTrader 2/8/2024 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 12/22/2023 US FDA approves AstraZeneca-Ionis's medicine
TeleTrader 4/14/2022 Canada approves AstraZeneca's Evusheld
TeleTrader 5/20/2021 Japan health expert panel okays AZ, Moderna jabs
TeleTrader 3/8/2021 Italy okays AstraZeneca's vaccine for people over 65
TeleTrader 1/29/2021 Producing vaccines is a bumpy road - AZ's Soriot
TeleTrader 1/29/2021 AstraZeneca must deliver jabs from UK to EU - Von der Leyen
TeleTrader 1/29/2021 EU publishes vaccine contract with AstraZeneca
TeleTrader 1/27/2021 EU to 'defend investments' in AstraZeneca's vaccine
TeleTrader 1/25/2021 AstraZeneca's vaccine not effective in elderly people - report
TeleTrader 1/24/2021 EU to make firms respect vaccine delivery deadlines - Michel
TeleTrader 12/12/2020 AstraZeneca to acquire Alexion for $39B
TeleTrader 11/23/2020 Johnson: Months needed to perform inoculation
TeleTrader 11/1/2020 AstraZeneca's vaccine reviewed by UK regulator
TeleTrader 10/26/2020 AstraZeneca: Vaccine trial results 'encouraging'
TeleTrader 10/21/2020 Brazil says volunteer died during Oxford vaccine trial
TeleTrader 10/18/2020 We'll have more than one vaccine in 2021 - UK expert
TeleTrader 10/16/2020 Switzerland secures 5.3M doses of AstraZeneca's vaccine
TeleTrader 10/14/2020 US expands AstraZeneca treatment collaboration
TeleTrader 10/7/2020 AstraZeneca could up vaccine price in 2021 - report
TeleTrader 10/2/2020 AstraZeneca: Vaccine trial resumes in Japan
TeleTrader 9/23/2020 Fauci: By end of 2020 we'll know if vaccines effective
TeleTrader 9/23/2020 UBS: Vaccine approval in Q4 to shift stock markets
TeleTrader 9/20/2020 AstraZeneca's vaccine trial still on hold in US - company
TeleTrader 12/30/2019 FDA approves Astra Zeneca, Merck & Co. drug